Daily Stock Analysis, ARE, Alexandria Real Estate Equities Inc, priceseries

Alexandria Real Estate Equities Inc. Daily Stock Analysis
Stock Information
Open
136.50
Close
138.66
High
139.96
Low
136.30
Previous Close
136.40
Daily Price Gain
2.26
YTD High
144.46
YTD High Date
Apr 8, 2019
YTD Low
109.92
YTD Low Date
Jan 2, 2019
YTD Price Change
28.04
YTD Gain
25.35%
52 Week High
144.46
52 Week High Date
Apr 8, 2019
52 Week Low
107.39
52 Week Low Date
Dec 26, 2018
52 Week Price Change
20.96
52 Week Gain
17.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 8. 2019
116.00
Feb 27. 2019
134.17
34 Trading Days
15.66%
Link
Company Information
Stock Symbol
ARE
Exchange
NYSE
Company URL
http://www.are.com
Company Phone
6265780777
CEO
Joel S. Marcus
Headquarters
California
Business Address
385 E. COLORADO BLVD, SUITE 299, PASADENA, CA 91101
Sector
Equity
Industry Category
Real Estate
Industry Group
REIT - Office
CIK
0001035443
About

Alexandria Real Estate Equities, Inc. operates as a real estate investment trust, which engages in the development through ownership, operation, management, selective acquisition, development, and redevelopment of properties containing life science laboratory space. It also provides real estate, technical infrastructure, and services to the diverse life science industry. The company was founded by Joel S. Marcus and Jerry M. Sudarsky in June 1994 and is headquartered in Pasadena, CA.

Description

Alexandria Real Estate Equities, Inc., a real estate investment trust (REIT), engages in the ownership, operation, management, development, acquisition, and redevelopment of properties for the life sciences industry. Its properties consist of buildings containing scientific research and development laboratories, and other improvements. The company offers its properties for lease primarily to universities and independent not-for-profit institutions; and pharmaceutical, biotechnology, medical device, life science product, service, biodefense, and translational research entities, as well as governmental agencies. As of December 31, 2006, it had 159 properties, including 156 properties located in 9 states in the United States and 3 properties located in Canada. As a REIT, the company is not subject to federal income tax to the extent that it distributes 100% of its taxable income to its stockholders. The company was founded in 1993 and is based in Pasadena, California.